Objectives: Estradiol is known to exert a protective effect against atherosclerosis, but the mechanism(s) whereby this protection is mediated is / are unclear. However, estradiol-treated castrated animals exhibit increased activity of endothelium-derived relaxing factor (EDRF), which could contribute to vasculoprotection. In the present work, we investigated the molecular mechanism(s) of the enhancement of EDRF activity in the thoracic aorta of oophorectomized female rats given 17b-estradiol (E , 2 or 40 mg / kg / day) 2 compared to those given a placebo. Methods and Results: The abundance in the thoracic aorta of NO synthase I, II and III mRNA (using RT-PCR) and of NO synthase I, II and III immunoreactive protein (using Western blotting) was unaltered by E . NO synthase activity 2 (based on arginine / citrulline conversion) in thoracic aorta homogenates did not differ significantly among the three groups, suggesting that NO production was not enhanced by E . In contrast, lucigenin-enhanced chemiluminescence of aorta from the E group was 2 2 decreased compared to that of the placebo group. Desendothelialization and exogenously added superoxide dismutase suggested that this 2?
(based on arginine / citrulline conversion) in thoracic aorta homogenates did not differ significantly among the three groups, suggesting that NO production was not enhanced by E . In contrast, lucigenin-enhanced chemiluminescence of aorta from the E group was 2 2 decreased compared to that of the placebo group. Desendothelialization and exogenously added superoxide dismutase suggested that this 2?
difference was due to a decrease in extracellular endothelium-derived production of superoxide anion (O ). Experiments in cultured 2 2?
bovine aortic endothelial cells confirmed a decreased extracellular production of O in response to ethinylestradiol (1 nM) using both 2 lucigenin-enhanced chemiluminescence and ESR spectroscopy. Luminol-enhanced chemiluminescence revealed that ethinylestradiol- endothelium-derived generation of O in response to estrogens could account for enhanced EDRF-NO bioactivity and decreased 2 1. Introduction DMPO, 5 ,5-dimethyl-1-pyrroline-N-oxide; DTPA, diethylenetriaminepentaacetic acid; ESR, electron spin resonance; E , 17b-estradiol; EE , than in premenopausal women but increases in post-2. Methods menopausal women. An abundance of epidemiological data supports a role for estrogens in this atheroprotective 2.1. Animal preparation, cell culture and materials effect, prompting recommendations for their widespread use in postmenopausal replacement therapy [1, 2] . HowAll experimental protocols were performed in accordever, the mechanism by which this protection is mediated ance with the recommendations of the French Accreditaremains obscure. It is traditionally thought to be due to tion of Laboratory Animal Care. A total of 110 female potentially favourable changes in blood lipids and lipoproSprague-Dawley rats (weighing 160-180 g; Iffa-Credo) teins [1] but a number of studies in humans [3] as well as were anaesthetized for bilateral ovariectomy. Ten days animals [4-6] strongly suggest a direct effect on the later, the castrated animals were administered either E (2 2 vascular system. or 40 mg / kg / day) or the vehicle (propanediol) subcutaEndothelium-derived relaxing factor (EDRF), identified neously for five days. The rats were then sacrificed with an as nitric oxide (NO), is a free radical messenger that is overdose of pentobarbital. The uterus was removed and able to induce relaxation of the vascular smooth muscle weighed. The thoracic aorta was removed, cleaned of cells [7] [8] [9] . The endothelial NO synthase, or NO synthase excess adventitial tissue, and care was taken not to injure III, which converts L-arginine to L-citrulline and NO, has the endothelium. been purified and its cDNA sequence determined [9] [10] [11] .
BAECs were obtained and grown as described previousEndothelial NO synthase is a complex enzyme whose ly [23, 24] in phenol red-free Dulbecco's Modified Eagle activity requires several cofactors (NADPH, FAD, FMN, medium supplemented with 10% heat-inactivated charcoaltetrahydrobiopterin) and depends on calmodulin and caltreated newborn calf serum at 378C in culture dishes (20 2 cium. NO synthase III activity is stimulated by numerous cm ) and in a 10% CO -containing humidified atmos-2 agonists (acetylcholine, bradykinin, etc.) or by a mechaniphere. The cells used in this study were between the fifth cal stimulus (shear stress). Increased shear stress also and fifteenth passage. Several measures were taken to appears to be the major determinant of NO synthase III avoid artifacts of cell culture on BAEC phenotype due to gene expression in vitro and in vivo [12, 13] . Even if NO or proliferation, as previously reported [25] . All passages a closely related compound accounts for EDRF, NO can be were made using a splitting ratio of 1:4. Confluency was al. [21] and Goetz et al. [22] reported that pharmacological BAECs four days after confluency (100 000 cells / cm ). doses of E induced an upregulation of NO synthase III
The cells for estrogen stimulation were treated with EE 2 2 mRNA abundance in guinea pig skeletal muscle and rat instead of estradiol, to prevent metabolism of the steroid aorta, respectively. However, we found that exposure of hormone [26] . cultured bovine aortic endothelial cells (BAECs) to physioAll reagents were purchased from Sigma (St. Louis, logical doses of estrogens did not alter NO synthase III MO, USA), except when specified. Protein concentrations gene expression, but induced a receptor-mediated antiwere determined using the Bio-Rad Coommasie Brilliant oxidant effect that enhanced the biological activity of Blue G-250 method, with bovine serum albumin as endothelium-derived NO [23] . To further elucidate the standard. molecular mechanisms by which estrogens enhance EDRF activity in vivo, we gave oophorectomized female rats 2.2. Isolated vascular ring experiments either placebo, or low or high doses of E and studied the 2 thoracic aorta for (1) EDRF activity, evaluated from the Ring segments (3 mm) of rat thoracic aorta were relaxation of precontracted aorta; (2) NO synthase III suspended in individual organ chambers filled with Krebs mRNA and protein abundance, as well as the gene buffer (20 ml production using lucigenin-enhanced chemiluminescence solution was aerated continuously with 95% O -5% CO   2  2 and, finally, (5) the effect of ethinylestradiol (EE ) in vitro and maintained at 378C. Care was taken not to injure the 2 on lucigenin-and luminol-enhanced chemiluminescence endothelium during ring preparation. Tension was recorded and on electron spin resonance (ESR) spectroscopy using with a linear force transducer. The resting tension was 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) as spin trap gradually increased to 1.5 g over a period of 1 h, and the using the BAEC culture model. ring segments were exposed to 80 mM KCl until the optimal tension for generating force during isometric The films were then scanned using a densitometer, and a contraction was reached. The vessels were left at this graph of peak area against protein concentration was resting tension throughout the remainder of the study. The plotted. A similar approach was used to detect the neuronal vessels were then precontracted with L-phenylephrine (0.5 and inducible NO synthase, with specific antibodies purmM). When a stable contraction plateau had been reached, chased from Transduction Laboratories. the rings were exposed cumulatively to either acetylcholine (ACh, 1 nM-3 mM) or sodium nitroprusside (SNP, 1 2.5. RNA isolation and RT-PCR amplification nM-3 mM).
2.5. TTCCGGCTGCCACCTGATCCTAA-39 (sense) and 59-AACATGTGTCCTTGCTCGAGGCA-39 (antisense), which amplify a 340 bp mRNA region. NO synthase 2.4. Western blotting analysis mRNA expression was calculated by normalizing NO synthase mRNA to GAPDH mRNA. Primers for GAPDH Protein homogenates were prepared as described above included 59-GTGAAGGTCGGAGTCAACG-39 (sense) for measurement of NO synthase activity. Protein was and 59-GGTGAAGACGC CAGTGGACTC-39 (antisense), size-fractionated electrophoretically using a 7.5% SDS which amplify a 299 bp mRNA region. The annealing polyacrylamide gel and transferred to nitrocellulose memtemperature for GAPDH primers was 558C, and the PCR branes that were blocked with 5% casein Tris-buffered was performed for 27 cycles. saline solution, pH 7.6, containing 0.1% Tween (TBS-T) at
The primers were chosen to encompass several introns room temperature. The membranes were incubated with a in order to avoid amplification of contaminating genomic 1:2000 (v / v) dilution of a monoclonal antibody against a DNA. A negative control was used for each set of samples peptide from the sequence of human endothelial NO to check the reverse transcription and the PCR amplificasynthase that cross-reacted with the rat and the bovine tion reagents for any contamination. PCR amplification enzymes (Transduction Laboratories, Lexington, KY), was verified to be exponential and the product was washed four times with TBS-T, then incubated with a proportional to the input. sheep anti-mouse secondary antibody conjugated to horseThe PCR products were separated on an 8% acrylamideradish peroxidase (Amersham) and washed again. Signals N-N9-(1,2-dihydroxyethylene)-bis-acrylamide (DHEBA) were detected using the ECL detection system (Amersham) (29:1) gel in a 13 TBE buffer using a miniprotean II cell and autoradiography films (Hyperfilm TM ECL, Amerapparatus (Biorad). DHEBA was obtained from ICN sham). Two dilutions (25 and 50 mg of protein per lane) Biochemicals. After ethidium bromide staining, the bands were analyzed to quantify the NO synthase protein content.
corresponding to the amplified fragments were excised, peak and the area under the curve (expressed in mV/ s) dissolved for 2 h at 508C in 750 ml of 25 mmol / l periodic were calculated using a Hewlett Packard 85 computer. acid and the radioactivity was counted in a b scintillation counter. On the negative control lane, gel slices corre-2.7. ESR measurements sponding to the position of these bands were excised, 2 counted and used as background.
BAECs cultured in a 25-cm flask were washed with PBS, and then incubated with a mix containing 150 mM 2.6. Lucigenin-and luminol-enhanced DMPO, 1 g / l glucose, 0.2 g / l CaCl , 0.0059 g / l dieth- O production from cultured cells, but are not sensitive supernatant was then transferred to a flat quartz cell that 2 enough to detect lucigenin-enhanced chemiluminescence was inserted in a TM 110 Bruker cavity. ESR spectra were elicited by aortic segments. We therefore followed a recorded at room temperature with an ER 200 D Bruker different approach that has been described previously spectrometer by starting a 3-min scan 5 min after the end [27, 28] . Lucigenin chemiluminescence was detected using of the incubation with the cells. The ESR spectrometer was a scintillation counter (Packard Tri-Carb 2100 TR) in operated at 9.66 GHz with high frequency at 100 kHz, a out-of coincidence mode. The descending thoracic aorta modulation amplitude of 1 Gauss, a time constant of 0.5 s, was isolated and removed, taking care not to damage the a microwave power of 10 mW, field: mid range at 3500 endothelium. Segments (1 cm) of thoracic aorta, freed of Gauss and scan range 200 Gauss. The intensity of the ESR adventicia, were incubated with Krebs-Hepes buffer mainsignal was calculated by adding the height of the four tained at 378C for 30 min and then gently transferred to peaks, and was expressed in arbitrary units. scintillation vials containing 250 mM lucigenin and other additions (final volume of 2 ml). Counts were obtained at 2.8. Statistical analysis 1-min intervals at room temperature for 15 min. The background, determined from vials containing all comThe data were expressed as mean6standard error. ponents with the exception of the aortic segment, was
Comparisons of data between two groups were made using subtracted from the values. Lucigenin-enhanced chemithe unpaired t-test. Comparisons of data between different luminescence with aortic rings was also measured in the groups were made by ANOVA and a Sheffe's post-hoc test
presence of an inactivator of O , superoxide dismutase was used when differences were indicated. p values ,0.05
(SOD, 150 U / ml), to assess extracellular O production. were considered to be significant. To assess endothelial O production, the endothelium was 2 removed, by gently rubbing the inner surface of the vessel with the closed tips of a thin forceps, and incubated with 3. Results Krebs-Hepes buffer maintained at 378C for 30 min. Lucigenin-enhanced chemiluminescence was then assessed 3.1. Effect of E on uterus weight and endothelium-2 from these desendothelialized vessels. dependent relaxation (EDRF) The production of reactive oxygen intermediates from BAECs was measured by chemiluminescence in the presCompared to placebo-treated ovariectomized rats, uterus ence of lucigenin or luminol. The medium was removed weight was increased 1.8-and 3.4-fold in rats given 2 and 2 from the 20 cm Petri dishes and the cells were washed 40 mg E / kg / day respectively ( glucose). BAECs (about 2?10 cells) were then scraped off significantly altered the contraction in response to the using a rubber policeman in 400 ml of HBSS and transa1-adrenergic agonist phenylephrine (Table 1) . When the ferred into a luminometer cuvette. The big cellular aggrevessels were precontracted to 70% of the maximal contracgates were then dissociated by gentle pipetting. Luminol tion, E dose-dependently increased EDRF activity, which 2 (66 mM final) or lucigenin (100 mM final) was then added. was estimated from the relaxation in response to acetylThe cuvette was put in a thermostatically (378C) controlled choline. The EC of the low dose E -treated group was 50 2 1251 LKB luminometer, as described previously. Chemisignificantly decreased in comparison to the placebo group luminescence was triggered with bradykinin (100 nM ( p50.03), but was borderline ( p50.08) in comparison to final) or the calcium ionophore A23187 (10 mM) (600 ml the high dose E -treated group ( Fig. 1 Table 1 ). There was 
and protein abundance in thoracic aorta
We studied the effect of E on the mRNA abundance of 2 NO synthases I, II and III in thoracic aorta using RT-PCR. GAPDH coamplification was used as a control. As shown in Table 2 , we did not find any difference in aorta mRNA abundance of the three NO synthases in response to E . We NO synthase III immunoreactivity in response to either the acetylcholine was then added in a cumulative fashion. The ANOVA with low or high E dose (Fig. 2) . We also examined the 2 repeated measures revealed that the dose-response curves of both doses presence of NO synthase I and II protein abundance using of E were statistically shifted leftwards in relation to the placebo, 2 monoclonal antibodies raised against sequences of human whereas E (2 mg / kg / day) and E (40 mg / kg / day) did not differ 2 2 significantly.
NO synthase I and II, respectively, but could not detect [ C]citrulline from both EE -treated and control cells was 2 abolished by removal of calcium and addition of 1 mM EGTA, and inhibited .90% by the addition of 30 mM L-NAME, an inhibitor of NO synthase (not shown).
Effect of E on lucigenin-enhanced
2 chemiluminescence from thoracic aorta were electrophoretically separated by polyacrylamide gel electrophoresis day). As shown in Fig. 3 extracellular O production of aortic endothelium. cultured BAECs (Fig. 4A) . The O production of BAECs E / kg / day) and placebo-treated rats. The NO synthase ( Table 2 ). The conversion of L-[ C]arginine into L-48 h). Similarly, bradykinin-stimulated production of O 2 was inhibited to a similar extent after EE pretreatment. (an inactivator of O ) and L-NAME (an inhibitor of NO 2 synthase activity). The signal of both control and EE -2 treated BAECs was found to be dependent on the enhanced
Effect of E on NO synthase activity in thoracic

Effect of EE on lucigenin-and luminol-enhanced aorta
production of both NO and O , leading to the conclusion 2 2 that peroxynitrite (ONOO ) is the oxidant species responsible for the activation of luminol. The luminol-enhanced enhanced chemiluminescence in response to bradykinin 
2?
resulting from the trapping of O , decomposes rapidly 2 into a more stable adduct: DMPO-OH [29] . To identify the reactive oxygen intermediate released by the BAECs and initially trapped by DMPO, the effects of SOD and catalase were tested as previously reported [30, 31] . When O . in BAECs is decreased in response to EE (1 nM). The ESR signal given by unstimulated (basal) cells was 4. Discussion less than two-fold that of the baseline (Fig. 1C) . After 15 minutes incubation of DMPO with control BAECs stimuOur aim in the above-described experiments was to lated by the calcium ionophore A23187 (10 mM), a typical examine the mechanism(s) by which E enhances EDRF 2 ESR signal was obtained, resulting from the DMPO-OH activity in vivo. We first found that the EDRF activity was adduct (Fig. 5A) . This adduct could result from hydroxyl increased in thoracic aorta from rats that had received a radical trapping by DMPO in the extracellular medium. low or high dose of E . This enhanced EDRF activity mRNA or protein abundance, or NO synthase activity, activity, estimated from the arginine / citrulline conversion strongly suggesting that it was not due to increased NO by thoracic aorta homogenates, was in agreement with the 2?
production. We then explored the production of O , which unaltered abundance of NO synthase III protein (Table 2   2 is an important mechanism of NO inactivation. In vivo, E Fig. 2) . Altogether, these data demonstrate that the en-2 treatment decreased the lucigenin-enhanced chemilumineshanced EDRF activity observed in aorta from E -treated 2 cence of thoracic aorta, demonstrating that estrogen treatrats is not due to an increase in NO production. only decreased O production, but also ONOO2 prosubstantial amounts of O , although the mechanisms of 2 2 duction. To the best of our knowledge, this is the first time production [NAD(P)H oxidase, xanthine oxidase, metabothat the enhancement of EDRF activity is promoted by a lism of arachidonic acid, etc.] have not been extensively 2?
decrease in O production mediated by a physiological characterized [42, 43] . Moreover, we previously reported 2 stimulus (i.e. E ) in vivo has been described. that EE did not enhance the expression of NO synthase in 2 2
Pregnancy increases EDRF activity in uterine arteries of BAECs, but increased the release of bioactive NO by 2?
guinea pigs [32] , rats [33] , sheep [34] and women [35] . inhibiting O production (evaluated by the technique of 2
The increased EDRF activity in uterine arteries was cytochrome c reduction) [23] . We therefore sought to 2?
shown, at least in part, to be due to increased NO assess O production in thoracic aorta from rats that had 2 production in pregnant guinea pigs [21] and in pregnant or had not received E . Three techniques are available for
sheep [34] . Pregnancy was also reported to increase EDRF the assessment of O production: ESR with spin trap such 2 activity and / or NO production in systemic arteries of rat as DMPO, ferricytochrome c reduction and lucigeninaorta [22, 36] and of rat mesenteric artery [36] . The enhanced chemiluminescence. This latter technique is the promoter regions of the human and bovine endothelial NO only one that is sensitive enough to detect the tiny amounts 2?
synthase genes have been sequenced, and several halfof O generated by a rat thoracic aorta [27, 28, 43, 44] (and 2 palindromes of the estrogen-responsive element sequence unpublished data). have been recognized [37, 38] , suggesting regulation at the In the first set of experiments, we found that lucigeninlevel of gene expression. However, their implication in NO enhanced chemiluminescence of thoracic aorta from cassynthase III gene expression is controversial [39, 40] , and trated rats treated with E was decreased by about 25% 2 other (indirect) mechanisms, such as increased shear stress compared to that of untreated rats. This difference could be nancy, only one study reported increased NO synthase III similarly lowered O production in untreated intact 2 mRNA abundance in systemic arteries after E treatment thoracic aorta but not in E -treated aorta. In the second set 2 2 [22] . It is noteworthy that a very high pharmacological of experiments, lucigenin-enhanced chemiluminescence dose was used in this study (1000 mg / kg / day, i.e. 25-fold elicited by EE -treated BAECs was decreased by about 2 higher than the high dose used in the present study). The two-fold compared to untreated cells. This confirmed that 2?
reason for the discrepancy between this previous work [22] estrogens inhibit endothelial O production, in agreement 2 and our results is unclear, although a very high pharmacowith the present in vivo data and with a previous in vitro logical dose can elicit non-saturable phenomena. The study (cultured BAECs) based on ferricytochrome c reducabsence of difference in NO synthase III mRNA abuntion [23] . Exogenous SOD inhibited three-quarters of the dance in placebo and E -treated vessels was confirmed at lucigenin-enhanced chemiluminescence from cultured ployed in the present study allowed comparison of the probably corresponded to extracellular O production by 2 detected signals using two dilutions of proteins from cultured BAECs. In contrast, only one-third of the placebo and E -treated thoracic aorta homogenates. We lucigenin-enhanced chemiluminescence of thoracic aorta 2 also investigated the NO synthase I and II mRNA and was inhibited by added SOD. One interpretation could be protein abundance in response to E , in particular, because that only one-third of the signal corresponds to extracellu-
NO synthase I (neuronal) was reported to be increased in lar O production in thoracic aorta. However, two other 2 the cerebellum under estrogens [21] and because NO explanations would seem more likely. Firstly, as the aortic synthase II (inducible) was reported to be increased in wall is a dense structure, extracellularly applied SOD will uterus during pregnancy [41] . However, in response to E , not gain access efficiently to the medial smooth muscle 2 the abundance of NO synthase I and II mRNA remained cells. Secondly, the lucigenin-enhanced chemiluminesunchanged and proteins remained undetectable in the aorta.
cence from smooth muscle cells could arise from an Finally, the absence of an effect of E on NO synthase intracellular source. In any case, it should be emphasized that the lucigenin-enhanced chemiluminescence from despecies involved in the atherosclerotic process, could help sendothelialized vessels was uninfluenced by E . Finally, to protect the vessel wall [56, 57] in endothelial NO synthase gene expression. We also Finally, the decreased generation of peroxynitrite, another
[17] Bell DR, Rensberger HJ, Koritnik DR, Koshy A. Estrogen pretreat-
